Donald L. Helseth

1.3k citations
19 papers · 744 indexed · h-index 12
Topics
Genomics and Rare Diseases (3 papers)Cancer Genomics and Diagnostics (3 papers)Virus-based gene therapy research (2 papers)

In The Last Decade

Donald L. Helseth

19 papers receiving 706 citations

Peers

Donald L. Helseth
Comparison fields: 5 of 94
  • Molecular Biology 310
  • Biomaterials 223
  • Cell Biology 154
  • Genetics 95
  • Oncology 73
Replace Jishun Lu with:
Jishun Lu Japan
J. Thomas United Kingdom
Ani Grigorian United States
D. Eichenberger France
Lizabeth A. Bourret United States
Simonetta Bernocco Italy
Piia Valonen Finland
Yamina Hamma‐Kourbali France
Tatiana Coelho‐Sampaio Brazil
B. Font France
Donald L. Helseth relative to Jishun Lu Japan Jishun Lu's profile →
Citations per field
00.5×3.5×
Jishun Lu · 1×
Citations per year

Countries citing papers authored by Donald L. Helseth

Since Specialization
Citations

This map shows the geographic impact of Donald L. Helseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald L. Helseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald L. Helseth more than expected).

Fields of papers citing papers by Donald L. Helseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald L. Helseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald L. Helseth. The network helps show where Donald L. Helseth may publish in the future.

Co-authorship network of co-authors of Donald L. Helseth

This figure shows the co-authorship network connecting the top 25 collaborators of Donald L. Helseth. A scholar is included among the top collaborators of Donald L. Helseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald L. Helseth. Donald L. Helseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 3
2 1
3 7
4 21
5 6
6 45
7 24
8 2
9 150
10 14
11 59
12 38
13 15
14 2
15 38
16 181
17 97
18 4
19 37

About Donald L. Helseth

Donald L. Helseth is a scholar working on Biotechnology, Cancer Research and Genetics, having authored 19 papers that have together received 744 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (3 papers), Cancer Genomics and Diagnostics (3 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biomaterials (223 citations), Cell Biology (154 citations) and Biotechnology (51 citations). Donald L. Helseth has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Arthur Veis, Gail V.W. Johnson, Alexander Schilling, Yuyu Song, Jeffrey W. Keillor, Scott T. Brady, Laura Kirkpatrick, Nicolas Chabot, David L. Geenen and R. John Solaro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026